Ali Health Announces Updated Board and Committee Composition Effective 15 May 2026

Bulletin Express05-14 18:02

Alibaba Health Information Technology Limited (Ali Health) has released an updated roster of its Board of Directors and related committee assignments, effective after the close of business on 15 May 2026. The re-constituted Board consists of seven members, divided as follows:

• Executive Directors: Chairman and Chief Executive Officer Shen Difan and Executive Director Sheng Mengyue.

• Non-executive Directors: Huang Jiaojiao and Xu Haipeng.

• Independent Non-executive Directors: Huang Yi Fei (Vanessa), Dr. Shao Rong and Wu May Yihong.

Committee roles have been adjusted to align with the new Board composition:

1. Audit Committee – Chair: Wu May Yihong – Members: Huang Jiaojiao, Huang Yi Fei (Vanessa), Dr. Shao Rong

2. Nomination Committee – Chair: Huang Yi Fei (Vanessa) – Member: Dr. Shao Rong

3. Remuneration Committee – Chair: Shen Difan – Members: Wu May Yihong and Dr. Shao Rong

The updated structure maintains a majority of independent non-executive directors, consistent with corporate governance best practices aimed at enhancing oversight and safeguarding shareholder interests.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment